PUBLISHER: Grand View Research | PRODUCT CODE: 1679509
PUBLISHER: Grand View Research | PRODUCT CODE: 1679509
The global ultra-high pressure balloon catheter market size is anticipated to reach USD 775.7 million by 2030 and is anticipated to grow at a CAGR of 9.42% during the forecast period, according to a new report by Grand View Research, Inc. The ultra-high pressure balloon catheter industry is experiencing significant growth due to rising prevalence of cardiovascular diseases, including coronary artery disease and peripheral arterial disease and growing adoption of minimally invasive procedures. For instance, the World Health Organization (WHO) reported that cardiovascular diseases are the primary cause of death worldwide, claiming approximately 17.9 million lives annually. In 2022, around 702,880 people died from heart disease in the U.S. which is equivalent of one in every five deaths. In addition, coronary heart disease is the most common type of heart disease. In 2022, around 371,506 died with coronary heart disease in the U.S.
With an aging population and increased lifestyle-related risk factors, the need for effective interventional cardiology solutions has surged. Moreover, increased healthcare expenditures and investments in medical technologies by hospitals and clinics are fostering market growth. Support from regulatory authorities, such as recent FDA and marketing approvals for new devices, enhances market accessibility and adoption. For instance, in March 2022, SIS Medical AG (Swiss Interventional Systems), one of the global manufacturers in interventional cardiology, announced the U.S. Food & Drug Administration's approval of its lead product, the OPN NC Super High Pressure PTCA Balloon Catheter.
One of the most notable advancements in the ultra-high pressure balloon catheter industry is the development of new materials and designs that improve the mechanical properties of the catheters. Manufacturers are investing in research and development to create ultra-thin, high-strength materials that can withstand higher pressures while maintaining a smaller profile. For instance, advancements in polymer technology have led to the creation of balloons that can expand significantly at high pressures without rupturing. This enables more effective dilatation of narrowed vessels, thereby improving the success rates of procedures. Manufacturers are increasingly offering a range of balloon sizes, shapes, and lengths that can cater to individual patient anatomies and specific clinical scenarios. This customization ensures that healthcare providers have the right tools at their disposal to address varying medical needs, promoting better procedural effectiveness and patient safety.